MHRA and DHSC prohibit export and hoarding of five ADHD medications amid shortage crisis


Share post:

The Department of Health and Social Care (DHSC) and the Medicines and Healthcare Products Regulatory Agency (MHRA) have added five more medicines that cannot be hoarded or exported from the UK market.

The government has taken the following action to address the “critical shortage” of attention deficit hyperactivity disorder (ADHD) drugs.

In a crucial development on October 9, this strategic move aims to enable wholesalers to fulfil their legal obligation to supply these essential medicines to patients across the UK.

The updated list of drugs incorporated “all” available strengths and pharmaceutical formulations, ensuring comprehensive coverage for patients’ medical needs.

• Methylphenidate hydrochloride

• Lisdexamfetamine mesylate

• Dexamfetamine sulfate

• Atomoxetine

• Guanfacine

As per rules, DHSC will prohibit the export of a medicine if it considers that the following conditions are met:

• the medicine is required to meet the needs of UK patients

• the medicine is currently in critical shortage or at risk of being in critical shortage

• the export of the medicine would contribute to a critical shortage, or risk of critical shortage, of that medicine in the UK

The breach of these restrictions could lead to regulatory action by the Medicines and Healthcare Products Regulatory Authority (MHRA) against the wholesale dealer’s license.

The consequences could range from an immediate license suspension or the suspension of specific product supplies under the license.


Please enter your comment!
Please enter your name here

Current Issue October 2023

Related articles

Over 81% of GP practices in England now provide patients’ health records online, says NHSE

In October alone, more than nine million people viewed their health records through the NHS App Thanks to...

Former Lloyds Pharmacy in Cumnock reopens as Rowlands Store

The new branch will be run by Pharmacy manager Meghan Mcewan and a team of colleagues from the...

Boots closing two stores in North Wales in early 2024

A petition has been launched to save a Boots pharmacy in Bournville from closure The pharmacy chain has already...

Living wage hike to incur up to £195 million in costs for pharmacy sector: CPE

Pharmacies have experienced a 30 per cent real terms funding reduction since 2015. The proposed increase in the national...